Germans Trias i Pujol Research Institute (IGTP)’s Post

🆕 A new study reveals the underuse of a key drug in patients with treatment-resistant schizophrenia This work by Germans Trias i Pujol Research Institute (IGTP)'s Psychiatry and Mental Health research group, in collaboration with Hospital del Mar-Instituto Hospital del Mar de Investigaciones Médicas (IMIM)'s ETEP group, has been published in the Spanish Journal of Psychiatry and Mental Health. The study highlights the underuse of clozapine in the first two years after the first psychotic episode, despite its proven benefits. The authors emphasize the need for more training and awareness for a broader and earlier implementation of clozapine in clinical practice. Learn more: https://lnkd.in/dq8qB5jY Alba Toll Privat Anna Mane #MentalHealth #Schizophrenia #Research #Clozapine

News

News

germanstrias.org

Hesham Sherif

Certified Psychiatrist in 3 different countries

2mo

Yes we know its underprescribed..but what is the reason? The reason is the patient has to take blood test weekly for like 6 months then every other week for more 6 months then monthly for the rest of time in addition to monitoring his heart condition and other investigations

Hesham Sherif

Certified Psychiatrist in 3 different countries

2mo

Useless

Like
Reply
Rodrigo Nardi

Founder of TRUE PSYCHIATRY NETWORK

2mo

😂😂😂😂😂

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics